The number-one question people ask before starting GLP-1 therapy isn't about side effects or efficacy — it's about cost. Insurance coverage for GLP-1 weight loss medications has improved significantly in 2026, but it remains inconsistent, confusing, and dependent on your specific plan type and where you live.
Commercial Insurance (Employer-Sponsored and Marketplace Plans)
Coverage varies dramatically by plan. The general trend: more employers are adding GLP-1 coverage in 2026 as evidence mounts that these medications reduce long-term healthcare costs (fewer diabetes cases, fewer cardiovascular events, fewer surgeries). But "covered" doesn't always mean "affordable."
Common commercial plan structures:
- Covered with prior authorization: The most common scenario. You meet BMI criteria, your doctor submits a PA, and the medication is covered at your plan's specialty drug tier — often with copays of $100–500/month.
- Step therapy required: You must try and fail on a cheaper medication first (phentermine, Contrave, or metformin). This adds months to the process but isn't necessarily a dead end.
- Excluded for weight loss: Some plans explicitly exclude weight loss medications from coverage, even if they cover the same drugs for diabetes. This is still legal in most states.
- Covered with wellness program requirement: Some plans require enrollment in a structured lifestyle program (nutrition counseling, activity tracking) alongside medication.
Medicare Coverage (New in 2026)
The biggest change in GLP-1 access this year: the Medicare GLP-1 Bridge program launches July 1, 2026. For the first time, Medicare will cover GLP-1 medications specifically for weight loss.
Key details:
- Covered drugs: Wegovy (injectable and oral), Zepbound (KwikPen), and Foundayo
- Cost: $50/month copay — that's the total out-of-pocket cost
- Duration: July 1, 2026 through December 31, 2027
- Eligibility: Must be enrolled in Part D (standalone PDP or Medicare Advantage with drug coverage)
- Clinical criteria: BMI ≥35 alone, or BMI ≥30 with heart failure/uncontrolled hypertension/CKD stage 3a+, or BMI ≥27 with pre-diabetes/prior heart attack/prior stroke/symptomatic PAD
- Important note: The $50 copay does NOT count toward your Part D out-of-pocket cap. The Bridge operates outside the normal Part D benefit.
If you're already on a GLP-1 for weight loss, you may still qualify — your prescriber attests that you met the BMI criteria when you first started treatment, even if you've lost weight since then.
Medicaid Coverage
Medicaid GLP-1 coverage is the most fragmented area. As of early 2026, approximately 13 states cover GLP-1 medications for weight loss under Medicaid, though more states are considering it under the new BALANCE Model that allows states to opt in starting May 2026.
States with confirmed Medicaid GLP-1 coverage tend to have higher eligibility thresholds (BMI ≥35 or ≥40) and may limit coverage duration. Check your state's Medicaid formulary or call your managed care plan for specifics.
How to Check Your Specific Coverage
- Call the number on your insurance card. Ask specifically: "Is semaglutide [or tirzepatide] covered under my prescription drug benefit for weight management?" Get the tier, copay, and PA requirements in writing if possible.
- Check your plan's formulary online. Most insurers publish their drug formulary on their website. Search for the medication by name.
- Ask about both brand-name and generic alternatives. Your plan may cover one brand but not another, or may prefer a specific formulation.
- Confirm manufacturer coupon eligibility. Novo Nordisk (NovoCare) and Eli Lilly (LillyDirect) offer savings cards that can reduce or eliminate copays for commercially insured patients.
Sesame Care
Brand-name GLP-1 prescriptions — FDA-approved medications only
From $39/visit
Paid link · Compounded medications are not FDA-approved and are prepared by licensed pharmacies.
No Insurance? Cash-Pay Options Starting at $99/mo
Paid links · Compounded medications are not FDA-approved.